Organoclick (Sweden) Probability of Future Stock Price Finishing Under 2.64
| ORGC Stock | SEK 2.65 0.04 1.53% |
Organoclick |
Organoclick Target Price Odds to finish below 2.64
The tendency of Organoclick Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to kr 2.64 or more in 90 days |
| 2.65 | 90 days | 2.64 | under 4 |
Based on a normal probability distribution, the odds of Organoclick to drop to kr 2.64 or more in 90 days from now is under 4 (This Organoclick AB probability density function shows the probability of Organoclick Stock to fall within a particular range of prices over 90 days) . Probability of Organoclick AB price to stay between kr 2.64 and its current price of kr2.65 at the end of the 90-day period is near 1 .
Assuming the 90 days trading horizon Organoclick has a beta of 0.13. This indicates as returns on the market go up, Organoclick average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Organoclick AB will be expected to be much smaller as well. Additionally Organoclick AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Organoclick Price Density |
| Price |
Predictive Modules for Organoclick
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Organoclick AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Organoclick Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Organoclick is not an exception. The market had few large corrections towards the Organoclick's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Organoclick AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Organoclick within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.15 | |
β | Beta against Dow Jones | 0.13 | |
σ | Overall volatility | 0.16 | |
Ir | Information ratio | -0.1 |
Organoclick Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Organoclick for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Organoclick AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Organoclick AB generated a negative expected return over the last 90 days | |
| Organoclick AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Organoclick AB has accumulated 24.85 M in total debt with debt to equity ratio (D/E) of 198.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Organoclick AB has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Organoclick until it has trouble settling it off, either with new capital or with free cash flow. So, Organoclick's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Organoclick AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Organoclick to invest in growth at high rates of return. When we think about Organoclick's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 110.06 M. Net Loss for the year was (32.69 M) with profit before overhead, payroll, taxes, and interest of 18.51 M. | |
| Organoclick AB has accumulated about 34.25 M in cash with (37.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. | |
| Roughly 35.0% of Organoclick outstanding shares are owned by corporate insiders |
Organoclick Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Organoclick Stock often depends not only on the future outlook of the current and potential Organoclick's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Organoclick's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 95.9 M | |
| Cash And Short Term Investments | 34.2 M |
Organoclick Technical Analysis
Organoclick's future price can be derived by breaking down and analyzing its technical indicators over time. Organoclick Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Organoclick AB. In general, you should focus on analyzing Organoclick Stock price patterns and their correlations with different microeconomic environments and drivers.
Organoclick Predictive Forecast Models
Organoclick's time-series forecasting models is one of many Organoclick's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Organoclick's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Organoclick AB
Checking the ongoing alerts about Organoclick for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Organoclick AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Organoclick AB generated a negative expected return over the last 90 days | |
| Organoclick AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Organoclick AB has accumulated 24.85 M in total debt with debt to equity ratio (D/E) of 198.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Organoclick AB has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Organoclick until it has trouble settling it off, either with new capital or with free cash flow. So, Organoclick's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Organoclick AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Organoclick to invest in growth at high rates of return. When we think about Organoclick's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 110.06 M. Net Loss for the year was (32.69 M) with profit before overhead, payroll, taxes, and interest of 18.51 M. | |
| Organoclick AB has accumulated about 34.25 M in cash with (37.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. | |
| Roughly 35.0% of Organoclick outstanding shares are owned by corporate insiders |
Additional Tools for Organoclick Stock Analysis
When running Organoclick's price analysis, check to measure Organoclick's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organoclick is operating at the current time. Most of Organoclick's value examination focuses on studying past and present price action to predict the probability of Organoclick's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organoclick's price. Additionally, you may evaluate how the addition of Organoclick to your portfolios can decrease your overall portfolio volatility.